Martin Dreyling
Overview
Explore the profile of Martin Dreyling including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
306
Citations
10752
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gutmair K, Villa D, Cunningham N, Silkenstedt E, Rimsza L, Ramsower C, et al.
Blood Adv
. 2025 Feb;
PMID: 39983085
No abstract available.
2.
Hoechstetter M, Hollwich E, Illner D, Pham T, von Bergwelt-Baildon M, Dreyling M, et al.
Eur J Haematol
. 2025 Jan;
114(4):690-699.
PMID: 39757858
Background: Pre-exposure prophylaxis with tixagevimab-cilgavimab significantly reduced severe COVID-19 outcomes in high-risk individuals during the pre-Omicron era (PROVENT trial). However, efficacy in patients with haematological malignancies (HM) was underreported. The...
3.
Shumilov E, Wurm-Kuczera R, Kerkhoff A, Wang M, Melchardt T, Holtick U, et al.
Blood Adv
. 2024 Dec;
PMID: 39661985
Glofitamab, a bispecific antibody targeting CD20 and CD3, is approved for relapsed/refractory diffuse large B-cell lymphoma (r/r DLBCL) after at least two prior treatment lines, but real-world data is scarce....
4.
Jiang L, Dreyling M, Hermine O, Mansmann U, Walewski J, Ribrag V, et al.
Br J Haematol
. 2024 Oct;
206(1):159-166.
PMID: 39442921
During a fatal disease, patients often request updated information on their prognosis. After patients have already survived a certain time, conditional survival captures their future survival probability. We investigated conditional...
5.
Khouja M, Jiang L, Pal K, Stewart P, Regmi B, Schwarz M, et al.
Leukemia
. 2024 Sep;
38(12):2675-2684.
PMID: 39284897
Recent studies highlighted genetic aberrations associated with prognosis in Mantle Cell lymphoma (MCL), yet comprehensive testing is not implemented in clinical routine. We conducted a comprehensive genomic characterization of 180...
6.
Tournilhac O, Altmann B, Friedrichs B, Bouabdallah K, Leclerc M, Cartron G, et al.
J Clin Oncol
. 2024 Sep;
42(32):3788-3794.
PMID: 39270145
JCO Primary analysis of the phase III randomized AATT study showed that younger patients with peripheral T-cell lymphoma (PTCL) consolidated with autologous or allogeneic transplantation (alloSCT) had similar event-free survival...
7.
Hubel K, Bower M, Aurer I, Bastos-Oreiro M, Besson C, Brunnberg U, et al.
Hemasphere
. 2024 Sep;
8(9):e150.
PMID: 39233903
This EHA-ESMO Clinical Practice Guideline provides key recommendations for managing HIV-associated lymphomas.The guideline covers clinical, imaging and pathological diagnosis; staging and risk assessment; treatment and follow-up.The author group encompasses a...
8.
Simon F, Ligtvoet R, Robrecht S, Cramer P, Kutsch N, Furstenau M, et al.
J Clin Oncol
. 2024 Aug;
43(4):381-391.
PMID: 39213466
Purpose: Surrogate end points are commonly used to estimate treatment efficacy in clinical studies of chronic lymphocytic leukemia (CLL). This patient- and trial-level analysis describes the correlation between progression-free survival...
9.
Fink K, Forster M, Oettle M, Buttner M, Eze C, Kasmann L, et al.
J Cancer Res Clin Oncol
. 2024 Aug;
150(8):407.
PMID: 39212783
Introduction: Training of interdisciplinary clinical reasoning and decision-making skills, essential in daily clinical practice in oncological specialties, are still underrepresented in medical education. Therefore, at LMU University Hospital Munich, we...
10.
Peloquin S, Cymbalista F, Dreyling M, Shah N, Murray S, Del Fiacco R, et al.
BMC Cancer
. 2024 Aug;
24(1):1003.
PMID: 39138575
Background: With recent advancements in the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), healthcare specialists may face challenges making treatment and management decisions based on latest...